MoneyWorks4Me

Alembic Pharmaceuticals submits press release

26 Jul 2025 Evaluate

Alembic Pharmaceuticals has submitted press release stating that Alembic Pharmaceuticals receives USFDA Final approval for Carbamazepine Extended-Release Tablets USP, 100 mg, 200 mg and 400 mg.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1756.90
Dr. Reddys Labs. 1195.10
Cipla 1303.30
Lupin 1960.00
Zydus Lifesciences 1115.10
View more..